TRUTH TALK NEWS: EXPOSING the MEDICAL INDUSTRIAL COMPLEX
TRUTH TALK NEWS: EXPOSING THE MEDICAL INDUSTRIAL COMPLEX – Broadcast LIVE on Wednesday, July 18, 2012 Host Howard Nema exposes the medical mafia and the Rockefeller bankster controlled cancer racket via research by Eustace Mullins’ work,”Murder by Injection”. Also a discussion about Sheng Wang, a Boston University cancer scientist who FABRICATED his findings for the Medical Mafia. His work was published in two journals in 2009, and he’s been ordered to retract them. But important studies by other scientists like those at the Mayo Clinic, who based their work on his findings, could now make 10 years of their studies worthless. The cancer industrial complex is a highly lucrative, well-oiled machine that tends to support funding for expensive drug treatments that don’t address the cause of the problem, and have yet to make a significant dent in the decrease of the overall cancer rate in the US despite investing hundreds of billions of dollars. Much support comes from flawed and biased “research” studies that support the use of expensive drugs as detailed in the featured articles. Researchers, too, are well aware of the notoriety and money to be found in cancer research — particularly what may be deemed successful cancer research (which unfortunately is often measured by the discovery of new drug treatments). As with many areas of medical research, it’s important to read between the lines of “scientifically proven” studies, even those that are well accepted. Many times you will discover the research gives the perception of science …
Austin drug and alcohol treatment center partners with A&E's "Intervention …
Filed under: drug treatment news articles
10, 2012 /PRNewswire-USNewswire/ — Austin Recovery, the largest and most affordable not-for-profit drug and alcohol treatment center in Texas, has teamed up with the Emmy® Award-winning "Intervention" program for the third time to save an addict's …
Read more on Sacramento Bee
PropThink: Geron Discontinues Imetelstat Phase 2 Breast Cancer Trial, Expects …
Filed under: drug treatment news articles
The drug is in Phase 2 trials for NSCLC and breast cancer with metastases in the brain. It delivers paclitaxel across the blood-brain barrier, a difficulty for many cancer treatments. Ahead of the bell, GERN is down 47%. To read PropThink's previous …
Read more on Reuters